BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oguz M, Lanitis T, Li X, Wygant G, Singer DE, Friend K, Hlavacek P, Nikolaou A, Mattke S. Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USA. Appl Health Econ Health Policy 2020;18:533-45. [PMID: 31849021 DOI: 10.1007/s40258-019-00542-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sciera LK, Frost L, Dybro L, Poulsen PB. The Cost-Effectiveness of One-Time Opportunistic Screening for Atrial Fibrillation in Different Age Cohorts of Inhabitants in Denmark Aged 65 Years and Above. A Markov Modelled Analysis. Eur Heart J Qual Care Clin Outcomes 2020:qcaa092. [PMID: 33337469 DOI: 10.1093/ehjqcco/qcaa092] [Reference Citation Analysis]
2 Khurshid S, Chen W, Singer DE, Atlas SJ, Ashburner JM, Choi JG, Hur C, Ellinor PT, McManus DD, Chhatwal J, Lubitz SA. Comparative Clinical Effectiveness of Population-Based Atrial Fibrillation Screening Using Contemporary Modalities: A Decision-Analytic Model. J Am Heart Assoc 2021;10:e020330. [PMID: 34476979 DOI: 10.1161/JAHA.120.020330] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ghazal F, Aronsson M, Al-Khalili F, Rosenqvist M, Levin LÅ. Cost-effectiveness of screening for atrial fibrillation in a single primary care center at a 3-year follow-up. Scand Cardiovasc J 2022;56:35-41. [PMID: 35389311 DOI: 10.1080/14017431.2022.2060523] [Reference Citation Analysis]